Natural Treatments for Prostate Cancer Provide Better Quality of Life

The campaigns raised money for new treatment options and have led to an increase in the number of cases caught during early stages of the disease.
Unfortunately, Men’s Health Month is only 30 days out of 365.
Whether to Watch And Wait: The Do Nothing Treatment Plan
From there, a biopsy can confirm the existence of prostate cancer.
But prostate cancer is a particularly frustrating disease. Even once it’s detected, existing tests cannot predict if a particular case will be aggressive or slow-growing.
In most cases, the cancer is slow growing and never progresses enough to impact a patient’s quality of life. In fact, according to health journalist and author of The Sensitive Gut Michael Lasalandra, most men will develop prostate cancer at some point in their lifetimes.
This has led to growing support of a treatment option called “watch and wait,” or monitoring of the prostate with no treatment, unless the cancer begins to progress.
Yet the idea of waiting while a cancer grows inside of you isn’t a pleasant one.
Natural Treatment Options To Reduce Risk of Prostate Cancer
Although definitive proof is lacking, there are behavior and dietary changes in this approach that have been shown, through both observational and clinical studies, to help mitigate the risk of developing an aggressive cancer and dying of the disease.
These include*:
- Making dietary changes that include reducing or eliminating red meat and dairy and eating lots of vegetables.
- Taking supplements of omega-3 fatty acids, vitamin D, AHCC and herbal anti-inflammatory agents.
- Adopting an exercise program that includes aerobic exercise three times a week.
- Practicing a method of stress reduction, like yoga or meditation.
- Getting a PSA test every three to four months and a digital rectal exam every six months.
- Repeating a biopsy of the prostate every 12 to 24 months.
*Source: A Watch-and-Wait Prostate Treatment The New York Times
The Search for Natural Treatments for Prostate Cancer
AHCC has been used worldwide as a potential treatment option for many chronic diseases such as cancer.
For example, a cohort trial of liver cancer patients who had part of their liver removed found that among patients who received AHCC, only 34.5 percent suffered a recurrence of their cancer, while in the control group 66 percent—almost twice as many—suffered a recurrence. Further, survival rates were higher in the AHCC group compared with the control.
In another study, AHCC was found to help ease the side effects of chemotherapy for patients with late-stage head and neck cancers. Patients had better appetites, felt stronger, and reported less nausea and vomiting when they took AHCC. Their white blood cell counts also improved and they suffered less constipation. In the prostate category a study on AHCC performed on 11 advanced cancer patients, three of whom had prostate cancer, found that the PSA levels of prostate cancer patients began dropping significantly after one to two months of treatment with AHCC and had fallen to normal levels by four months.
The results of one such study in 74 prostate cancer patients, published in the Japanese Journal of clinical Oncology, suggested that AHCC contributed to the stabilization of the disease status of early stage prostate cancer in patients who were being expectantly monitored.
The results of this study and several others have led AHCC to be recommended to many men who have been diagnosed with early-stage prostate cancer and who are otherwise undergoing a “watch and wait” plan.
Have you or someone you know been told that your best treatment option is to “watch and wait”? Share your story in the comments below.